THE EFFECT OF NON-VITAMIN K ANTAGONIST ORAL ANTICOAGULANTS ON RENAL OUTCOMES IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION.

被引：0
|
作者：
Deeprom, Siwaporn [1 ,2 ]
Chirananthavat, Thanit [2 ]
机构：
[1] San Pa Tong Hosp, Med, Chiangmai, Thailand
[2] Police Gen Hosp, Nephrol, Bangkok, Thailand
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2020年 / 35卷
关键词：
D O I：
暂无
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
P0706
引用
收藏
页码：1028 / 1028
页数：1
相关论文
共 50 条
  • [31] Effectiveness and safety of non-vitamin k antagonist oral anticoagulants in patients with atrial fibrillation and valvular heart disease
    Moon, I. K.
    Lee, S. R.
    Choi, E. K.
    Lee, E. J.
    Jung, J. H.
    Han, K. D.
    Cha, M. J.
    Oh, S. I.
    Lip, G. Y. H.
    EUROPEAN HEART JOURNAL, 2019, 40 : 2984 - 2984
  • [32] Appropriate Dosing Regimens of Non-Vitamin K Antagonist Oral Anticoagulants for Treatment of Patients With Non-Valvular Atrial Fibrillation: An Evidence-Based Consideration
    Zhao, Shujuan
    Hong, Xuejiao
    Cao, Jingjing
    Cai, Haixia
    Du, Song
    Ma, Peizhi
    FRONTIERS IN PHARMACOLOGY, 2020, 11
  • [33] Dosing issues with non-vitamin K antagonist oral anticoagulants for the treatment of non-valvular atrial fibrillation: Why we should not underdose our patients
    Dillinger, Jean-Guillaume
    Aleil, Boris
    Cheggour, Saida
    Benhamou, Ygal
    Bejot, Yannick
    Marechaux, Sylvestre
    Delluc, Aurelien
    Bertoletti, Laurent
    Lellouche, Nicolas
    ARCHIVES OF CARDIOVASCULAR DISEASES, 2018, 111 (02) : 85 - 94
  • [34] Effectiveness and safety of non-vitamin K antagonist oral anticoagulants in patients with non-valvular atrial fibrillation: A nationwide, population-based study in Korea
    Han, Seongwook
    Han, Sola
    Suh, Hae Sun
    Bang, Oh Young
    On, Young Keun
    Lee, Myung-Yong
    Jang, Sung-Won
    Won, Mi-Mi
    Park, Yoo-Jung
    Lee, Ji-Min
    Kang, Seongsik
    Kim, Young-Hoon
    JOURNAL OF ARRHYTHMIA, 2021, 37 (05) : 1240 - 1249
  • [35] Comparison of non-vitamin K antagonist oral anticoagulants and warfarin on clinical outcomes in atrial fibrillation patients with renal dysfunction
    Lee, Ki Hong
    Park, Hyung Wook
    Cho, Jeong Gwan
    Yoon, Nam Sik
    Kim, Sung Soo
    Kim, Mi Ran
    Kim, Min Chul
    Cho, Kyung Hoon
    Kim, Hyun Kuk
    Kim, Cheol Hwan
    Kim, Kyung Hwan
    Jun, Seung Jin
    Kim, Woo Jin
    Lee, Kyoung Jin
    Jeong, Hae Chang
    Cho, Jae Yeong
    Park, Keun-Ho
    Sim, Doo Sun
    Yoon, Hyun Ju
    Kim, Kye Hun
    Hong, Young Joon
    Kim, Ju Han
    Ahn, Youngkeun
    Jeong, Myung Ho
    Park, Jong Chun
    EUROPACE, 2015, 17 : 69 - 75
  • [36] Non-vitamin K oral anticoagulants in 'valvular' atrial fibrillation: a call for action
    Steffel, Jan
    Atar, Dan
    EUROPACE, 2016, 18 (01): : 1 - 3
  • [37] Clinical outcomes in atrial fibrillation patients with non-vitamin K antagonist oral anticoagulants and heart failure
    Goena Vives, C.
    Quintas Ovejero, L.
    Garcia Martin, R.
    Lluis Serret, I.
    Taboada Gomez, J.
    Rilo Miranda, I.
    Beramendi Calero, J. R.
    Telleria Arrieta, M.
    EUROPEAN JOURNAL OF HEART FAILURE, 2017, 19 : 243 - 243
  • [38] Number needed to treat based on real-world evidence for non-vitamin K antagonist oral anticoagulants versus vitamin K antagonist oral anticoagulants in stroke prevention in patients with non-valvular atrial fibrillation
    Briere, Jean-Baptiste
    Bowrin, Kevin
    Millier, Aurelie
    Toumi, Mondher
    Wojciechowski, Piotr
    Taieb, Vanessa
    JOURNAL OF MEDICAL ECONOMICS, 2019, 22 (08) : 760 - 765
  • [39] Reply to "Non-vitamin K antagonist oral anticoagulants for atrial fibrillation in obese patients"
    Gupta, Rajeev
    Desai, Rupak
    Gupta, Neelesh
    AMERICAN JOURNAL OF CARDIOLOGY, 2020, 130 : 167 - 168
  • [40] Non-vitamin K antagonist oral anticoagulants in older and frail patients with atrial fibrillation
    Giugliano, Robert P.
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2022, 24 : A1 - A10
12345